Health effects of tobacco

Pure Extracts Signs White Label Agreement with British Columbia-Based Green Light Solutions

Retrieved on: 
Tuesday, July 20, 2021

These products will be created by collaboration between the two companies with a reliance on Pure Extracts 30+ proprietary formulations and its optimized vape hardware.

Key Points: 
  • These products will be created by collaboration between the two companies with a reliance on Pure Extracts 30+ proprietary formulations and its optimized vape hardware.
  • Pure Extracts will be providing co-manufacturing extraction services including all sales and distribution, labelling, packaging, applying of excise stamps and shipping.
  • We are confident that Pure Extracts capabilities and market philosophy will enable us to disrupt the CBD vape category.
  • Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia.

CV Sciences, Inc. and University of California, San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence

Retrieved on: 
Tuesday, July 20, 2021

The Company, in collaboration with researchers from the University of California, San Diego (UC San Diego), published a preclinical study demonstrating the efficacy of chronic CBD treatment in reducing nicotine dependence using measures of withdrawal symptoms.

Key Points: 
  • The Company, in collaboration with researchers from the University of California, San Diego (UC San Diego), published a preclinical study demonstrating the efficacy of chronic CBD treatment in reducing nicotine dependence using measures of withdrawal symptoms.
  • In this study, rats dependent on nicotine and experiencing withdrawals were treated with CBD.
  • Treatment prevented the animals from exhibiting withdrawal symptoms including increased pain sensitivity and weight gain during short- and long-term nicotine restriction.
  • The patent covers methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing CBD and nicotine.

22nd Century Group to Host Webcast to Provide Business Update and Discuss Second Quarter 2021 Results

Retrieved on: 
Monday, July 19, 2021

BUFFALO, N.Y., July 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, will host a live webcast on Thursday, August 5, 2021, at 10:00 AM ET to discuss its 2021 second quarter results.

Key Points: 
  • BUFFALO, N.Y., July 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, will host a live webcast on Thursday, August 5, 2021, at 10:00 AM ET to discuss its 2021 second quarter results.
  • 22nd Century will report the Companys second quarter 2021 results in a press release at 6:00 AM ET the same day.
  • During the webcast, James A. Mish, chief executive officer; Michael Zercher, chief operating officer; and John Franzino, chief financial officer, will review the Companys 2021 second quarter results, growth opportunities, and innovative strategic plans and future initiatives in the more than $1.3 trillion global addressable markets.
  • Following prepared remarks, including an accompanying slide presentation, the Company will host a Q&A session, during which management will accept questions from interested analysts.

Healthier Choices Management Corp. Announces Issuance of Patent for “Bulb” Technology Vaping Cartridge

Retrieved on: 
Monday, July 19, 2021

This patent grant expands HCMC's portfolio of patent assets that promote a healthier way to vape.

Key Points: 
  • This patent grant expands HCMC's portfolio of patent assets that promote a healthier way to vape.
  • The issuance of this patent is significant in our attempts to make vaping safer.
  • Essentially, this patent is technologically the reverse process of our previously issued patents for our Q-Cup technology, said Jeff Holman, CEO of HCMC.
  • AboutHealthier Choices Management Corp.
    Healthier Choices Management Corp. ( www.healthi e rcmc.com ) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives.

Latin America E-Cigarette Market Report 2021: Current Trends and Future Perspectives - ResearchAndMarkets.com

Retrieved on: 
Friday, July 16, 2021

The "E-Cigarette Market Report: Current Trends and Future Perspectives for Latin America" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "E-Cigarette Market Report: Current Trends and Future Perspectives for Latin America" report has been added to ResearchAndMarkets.com's offering.
  • Latin America, which covers most of central and south America, is a hugely diverse region and has faced numerous economic and political challenges.
  • If you are interested in vaping markets across Latin America then this is the report for you.
  • In addition to extensive individual country analysis, the report explores key trends and identifies future perspectives for each country across the region.

Global Head and Neck Cancer Therapeutics Markets, Competition Forecast & Opportunities, 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 15, 2021

The Global Head and Neck Cancer Therapeutics Market is expected to witness significant CAGR of 7.71% during the forecast period to reach USD2934.26 million owing to rising patient pool suffering from head and neck cancer around the world.

Key Points: 
  • The Global Head and Neck Cancer Therapeutics Market is expected to witness significant CAGR of 7.71% during the forecast period to reach USD2934.26 million owing to rising patient pool suffering from head and neck cancer around the world.
  • This is acting as major growth driver for the Global Head and Neck Cancer Therapeutics Market.
  • To estimate and forecast the market size of the Global Head and Neck Cancer Therapeutics Market from 2021 to 2026 and growth rate until 2026.
  • To identify and analyze the profile of leading players operating in the Global Head and Neck Cancer Therapeutics Market.

United Kingdom E-cigarette Flavour Report 2021: Sweet and Candy Flavours Prevail - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 15, 2021

The "E-cigarette Flavour Report: Sweet and Candy Flavours Prevail in the UK" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "E-cigarette Flavour Report: Sweet and Candy Flavours Prevail in the UK" report has been added to ResearchAndMarkets.com's offering.
  • Are you interested in the UK market and how consumer preferences have changed?
  • If so then this report will provide you with detailed analysis of the online channel and how the products offered have evolved to match consumer demand.
  • You'll be able to compare the UK data with other large European markets, and gain a better understanding of flavours in the UK.

Thynk Health Welcomes Kim Parham as Vice President of Strategic Partnerships and Clinical Liaison

Retrieved on: 
Monday, July 12, 2021

LEXINGTON, Ky., July 12, 2021 /PRNewswire/ -- Thynk Health, the Complete Lung Cancer Screening Solution, announced and welcomed Kim Parham as VP of Strategic Partnerships and Clinical Liaison as the company enters into a new wave of growth and business development.

Key Points: 
  • LEXINGTON, Ky., July 12, 2021 /PRNewswire/ -- Thynk Health, the Complete Lung Cancer Screening Solution, announced and welcomed Kim Parham as VP of Strategic Partnerships and Clinical Liaison as the company enters into a new wave of growth and business development.
  • She is excited to be joining the Thynk Health team offering technology solutions that improve patient outcomes while helping increase facility revenue.
  • Thynk Health is on a mission to save lives lost to lung cancer by disrupting outdated, burdensome lung cancer screening processes.
  • Thynk Health's platform optimizes data-driven workflows and provides operational and clinical analytics for cancer screening programs and incidental findings management.

The Parent Company Expands Value Vape Offering with Launch of Fun Uncle Cruisers Vapes with Live Resin

Retrieved on: 
Monday, July 12, 2021

"As we grow our presence in the value vape category, The Parent Company is making strides towards its goal of becoming the clear industry leader.

Key Points: 
  • "As we grow our presence in the value vape category, The Parent Company is making strides towards its goal of becoming the clear industry leader.
  • The introduction of Fun Uncle Cruisers with Live Resin follows on the heels of the recent launch of Cruisers vapes, the brand's first vape offering.
  • Cruisers with Live Resin leverage The Parent Company's extraction process to deliver high-quality, potent distillate that is blended with high-terpene extract from flash-frozen flower.
  • Fun Uncle Cruisers with Live Resin are available at Caliva retail stores as well as through delivery at Caliva.com .

Pivot's Breath Sensor Receives Expanded Indications for Use from FDA

Retrieved on: 
Monday, July 12, 2021

As the only over-the-counter, FDA-cleared breath sensor for smoking cessation, Pivots Carbon Monoxide Breath Sensor provides innovative technology that goes beyond measuring the impact of smoking cessation: The sensor has now been proven to increase a persons motivation to quit.

Key Points: 
  • As the only over-the-counter, FDA-cleared breath sensor for smoking cessation, Pivots Carbon Monoxide Breath Sensor provides innovative technology that goes beyond measuring the impact of smoking cessation: The sensor has now been proven to increase a persons motivation to quit.
  • The new FDA clearance allows Carrot to highlight this expanded indication in its labeling and promotion of the sensor.
  • The emergence of an over-the-counter breath sensor that can help people quit tobacco is comparable to when consumer grade glucose meters became available, empowering people in their own diabetes care.
  • In the clinical trial supporting the expanded indications of the Pivot Breath Sensor, Carrot tested the device with 234 heavy tobacco users.